Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
Nirsevimab beschermt tegen ondersteluchtweginfectie door RS-virus
okt 2021 | Virale infecties